DBV Technologies reported $14.47M in Trade Creditors for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
DBV Technologies DBVT:US USD 14.47M 896K
Acadia Pharmaceuticals ACAD:US USD 12.75M 2.74M
Alnylam Pharmaceuticals ALNY:US USD 98.09M 57.52M
Amarin AMRN:US USD 93.16M 23.15M
Esperion Therapeutics ESPR:US USD 23.04M 4.46M
Galectin Therapeutics GALT:US USD 2.35M 612K
Halozyme Therapeutics HALO:US USD 17.69M 473K
Insmed INSM:US USD 52.61M 41.03M
Intercept Pharmaceuticals ICPT:US USD 14.23M 7.07M
IONIS PHARMACEUT IONS:US USD 17.92M 2.62M
Ptc Therapeutics PTCT:US USD 27.27M 6.41M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Ultragenyx Pharmaceutical RARE:US USD 43.27M 19.74M
YTE INCY:US USD 277.55M 114.37M